Next generation imaging and image-guided diagnosis and therapy for cancer
This Horizon Europe Research and Innovation Action, "Next generation imaging and image-guided diagnosis and therapy for cancer" (HORIZON-JU-IHI-2022-01-02), sought to advance cancer care. The program aimed to develop and enhance innovative, image-guided diagnostic and therapeutic solutions for cancer patients by integrating advanced imaging data and artificial intelligence. The call for proposals is now closed.
Who is Funded
This section details the eligibility criteria for applicants, the geographic scope of the program, and its overarching objectives, ensuring that funding targets organizations and projects aligned with enhancing cancer care through advanced imaging and AI.
What is Funded
This section outlines the types of projects and thematic areas eligible for funding, emphasizing the development of innovative imaging and AI-driven solutions for cancer. It also addresses the general categories of eligible costs and the developmental stages of projects supported.
Type and Scope of Funding
This section provides an overview of the financial support available, including the type of financial instrument and the funding amounts for successful proposals, clarifying the overall financial framework of the program.
Conditions and Requirements
This section highlights the critical conditions and requirements for applicants, covering aspects related to application submission, consortium formation, and other specific provisions governing the program.
Application Procedure
This section outlines the process for submitting applications, from document preparation to the evaluation and award process, providing essential procedural information for prospective participants.
Legal Basis
This section identifies the foundational legal instruments and policies that govern the "Next generation imaging and image-guided diagnosis and therapy for cancer" funding program, ensuring its operation within the established European regulatory framework.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
20,000,000 € per project
Allocated Budget:
The indicative budget for Call 1 in 2022 across relevant topics was 135,000,000 €.
Deadline:
20.09.2022
Award Channel:
Framework Programme Call
Region:
European Union member states and associated countries. Funding provisions may also be available for participants from certain non-EU/non-associated countries as detailed in the Horizon Europe Programme Guide.
Sectors:
Healthcare, Medical Technology, Research and Development, Information and Communication Technology, Pharmaceutical Industry
Beneficiaries:
Cancer patients, healthcare professionals, national health systems, healthcare providers
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization, Implementation, Service Delivery
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
IHI JU
Additional Partners:
Romanian Standards Association - ASRO, C4G - CONSULTING AND TRAINING NETWORK, LDA, SYNLAB International GmbH, SCANOMED ORVOSI, DIAGNOSTIKAI, KUTATO ES OKTATO KFT, LifestylediagnostiX, Guven Future Health Technologies INC, ACCENT PRO 2000 s.r.l., REPADO LOGISMIKOTECHNIKI-IPIRESIESEREYNAS KAI ANAPTIXIS EPE, SYNYO GmbH, LINAC-PET SCAN OPCO LIMITED, Rhino Health Ltd, Innoplexus, Green NanoTech, FUNDACION PRIVADA HOSPITAL ASIL DEGRANOLLERS, GRANT GARANT SRO, DYNAMEDICS S.R.L., Metabio IKE, ELVESYS, SABANCI UNIVERSITESI NANOTEKNOLOJI ARASTIRMA VE UYGULAMA MERKEZI SUNUM, Flow Analysis and Simulation Team, BCN HEALTH ECONOMICS & OUTCOMES RESEARCH S.L., Papanikolaou Hospital, RISC SOFTWARE GMBH, AEONX AI, CONSULTECH TECHNOLOGIEBERATUNG GMBH, TECH2MARKET SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA, OTTO-VON-GUERICKE-UNIVERSITAET MAGDEBURG, CENTRO SA.NA. SERVIZI SANITARI PRIVATI SRL, ACROSSLIMITS LTD, BUKOVINIAN STATE MEDICAL UNIVERSITY, CARDET CENTRE FOR THE ADVANCEMENT OF RESEARCH & DEVELOPMENT IN EDUCATIONAL TECHNOLOGY LIMITED, Red Hospitalaria Recoletas, URATIM GYARTO KORLATOLT FELELOSEGU TARSASAG, QUBIOTECH HEALTH INTELLIGENCE SL (R.M.A CORUNA), KLINICKI BOLNICKI CENTAR RIJEKA, EDELWEISS CONNECT GMBH, SIEC BADAWCZA LUKASIEWICZ - PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII, NUROMEDIA GMBH, Infrared Software Research and Development Consultancy Engineering Ltd., Robigem, DEEPLAB IKE, FUNDACION PARA LA INVESTIGACION MEDICA APLICADA FIMA
Website: